1999 Fiscal Year Final Research Report Summary
Establishment of quantitative RT-PCR method to defect drug-resistant-related genes
| Project/Area Number |
09672348
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Laboratory medicine
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
FUNATO Tadao Tohoku University, Hospital, Lecturer, 医学部附属病院, 講師 (70165455)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HOSHINO Atsushi Tohoku University, Hospital, Lecturer, 医学部附属病院, 講師 (60241600)
|
|---|
| Project Period (FY) |
1997 – 1999
|
| Keywords | drug resistance / leukemia / real-time RT-PCR / Multidrug reistance / cytosine arabinoside |
|---|
| Research Abstract |
The failure of chemotherapy to eradicate human leukemic cells is often due to the development of drug resistance. MDR (multidrug resistance) whose one form of drug resistance results from a decreased intracellular accumulation of the drugs, most often mediated by the overexpression of P-glycoprotein. Multidrug-related protein (MRP) also related to pump function of cell membrane in acute leukemia. Decreased deoxycytidine kinase (dCK) gene was observed in cytosine arabinoside resistant leukemia cells (ara-C) which we have established. We have developed the new quantitative assay based on real-time reverse transcriptase polymerase chain reaction (RT-PCR) to mesure expression of drug-resistance related genes such as MDR-1, MRP, and dCK in clinical samples. These results indicates that real-time RT-PCR system is a releable method to quantitatively determine drug resistant genes expression, it may be to predict responsiveness to chemotherapy by using this technique.
|
